NewAmsterdam Pharma Company N.V. Ordinary Shares (NASDAQ: NAMS) last traded at $27.87, up 0.32% on the session. The quote above updates while this page is open; the figures below are drawn from NewAmsterdam Pharma Company N.V. Ordinary Shares’s own filings and are restated only when a new one is published.
NewAmsterdam Pharma Company N.V. Ordinary Shares trades on NASDAQ under the ticker NAMS. Its market capitalisation is $3.33 billion.
Valuation measures for NewAmsterdam Pharma Company N.V. Ordinary Shares, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.33B |
|---|---|
| Enterprise value | $2.98B |
| Price / sales | 467.84 |
| Price / book | 5.28 |
| Beta | 1.02 |
Trailing-twelve-month figures tagged in NewAmsterdam Pharma Company N.V. Ordinary Shares's XBRL filings with the SEC.
| Revenue (TTM) | $7.12M |
|---|---|
| Net income (TTM) | -$259.50M |
| EPS (TTM) | -$2.15 |
| Operating margin | -3432.20% |
| Return on equity | -41.10% |
| Cash | $424.15M |
Range and volume for NAMS over the past 52 weeks.
| 52-week high | $42.21 |
|---|---|
| 52-week low | $23.05 |
| Volume | 513.5K |
| Average volume | 1.13M |
| Previous close | $27.78 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.